Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Drug Resistance, Bacterial -- genetics : Efflux-mediated antimicrobial resistance in bacteria : mechanisms, regulation and clinical implications / Xian-Zhi Li, Christopher A. Elkins, Helen I. Zgurskaya, editors
Drug resistance -- Cambodia : PBS NewsHour. Fighting malaria in the remote reaches of Cambodia / [produced by NewsHour Productions]
2019
1
Drug resistance -- Case studies : Addressing the antibiotic resistance crisis : Velcuva Pharmaceuticals' challenges and future opportunities / Vesela Veleva, Berkeley W. Cue Jr
Drug Resistance -- ethics : Ethics and drug resistance : collective responsibility for global public health / Euzebiusz Jamrozik, Michael Selgelid, editors
Drug resistance in microorganisms -- Developing countries : Antimicrobial resistance in developing countries / Aníbal de J. Sosa [and others], editors ; foreword by Thomas F. O'Brien ; introductory preface by the editors ; guest preface by Stuart B. Levy
Drug resistance in microorganisms -- Economic aspects -- Congresses : Understanding the economics of microbial threats : proceedings of a workshop / V. Ayano Ogawa, T. Anh Tran, and Cecilia Mundaca Shah, rapporteurs ; Forum on Microbial Threats, Board on Global Health, Health and Medicine Division, the National Academies of Sciences, Engineering, and Medicine
Drug resistance in microorganisms -- Prevention -- Government policy -- Congresses : Combating antimicrobial resistance : a One Health approach to a global threat : proceedings of a workshop / Ceci Mundaca-Shah, V. Ayano Ogawa, and Anna Nicholson, rapporteurs ; Forum on Microbial Threats, Board on Global Health, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine